---
title: "Gujarat Terce Laboratories Ltd (524314) — Share Price, Financials & Analysis"
symbol: "524314"
company: "Gujarat Terce Laboratories Ltd"
canonical: "https://tapetide.com/stocks/524314"
isin: "INE499G01013"
nse_symbol: "GUJARATTERCELABORATORIESLTD"
bse_code: "524314"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 32.76
generated_at: "2026-09-13T19:16:35.701Z"
---

# Gujarat Terce Laboratories Ltd (524314)

Canonical page: https://tapetide.com/stocks/524314

## Company

- **NSE Symbol:** GUJARATTERCELABORATORIESLTD
- **BSE Code:** 524314
- **ISIN:** INE499G01013
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** gujaratterce.in

## About

Incorporated in 1985. Gujarat Terce Laboratories Ltd is engaged in development, manufacturing, marketing and distribution of medicines, healthcare products and branded generics

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:47:48.624228Z.

- **Market Cap:** ₹32.76 Cr
- **Classification:** Microcap
- **P/E (reported):** 15.3
- **EPS (TTM):** ₹2.77
- **EPS (reported):** ₹0
- **Book Value:** ₹12.49
- **Price to Book:** 3.28
- **Dividend Yield:** 0%
- **ROE:** 22.63%
- **ROCE:** 23.61%
- **Debt to Equity:** 0.13
- **Revenue (yearly):** ₹47.8 Cr
- **Net Income:** ₹2.2 Cr
- **EBITDA:** ₹4.1 Cr
- **52-Week High:** ₹59.78
- **52-Week Low:** ₹29
- **RSI (14):** 58.39

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Rising
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 48.09 | 9% |
| growth | 27.84 | 9% |
| momentum | 60.52 | 12% |
| ownership | 50 | 24% |
| quality | 49.6 | 22% |
| valuation | 55.23 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has a low return on equity of 7.77% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -44.12% | -34.23% | 488.64% |
| ebitda margin growth | -64.71% | 3.01% | 159.88% | 142.9% |
| net income growth | -75% | -320% | 51% | 25% |
| revenue growth | 2% | -5.35% | 0% | 14% |
| roce | — | -36.82% | 115.42% | 12.36% |
| roe | — | -249.77% | 3.65% | 121.43% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12.03 | 13.02 | 12.21 | 11.89 | 13.3 | 12.68 | 12.32 | 10.85 | 12.93 | 12.29 | 11.4 | 9 |
| Expenses | 11.48 | 12.18 | 11.2 | 11.81 | 11.64 | 11.6 | 11.27 | 10.86 | 11.03 | 11.16 | 10.66 | 9.49 |
| Operating Profit | 0.55 | 0.84 | 1.01 | 0.08 | 1.66 | 1.08 | 1.05 | -0.01 | 1.9 | 1.13 | 0.74 | -0.49 |
| OPM % | 4.57 | 6.45 | 8.27 | 0.67 | 12.48 | 8.52 | 8.52 | -0.09 | 14.69 | 9.19 | 6.49 | -5.44 |
| Other Income | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.07 | 0.09 | 0.09 | 0.05 | 0.13 | -0.37 | 0.48 |
| Interest | 0.2 | 0.16 | 0.15 | 0.13 | 0.13 | 0.08 | 0.07 | 0.05 | 0.07 | 0.04 | 0.03 | 0.03 |
| Depreciation | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.13 | 0.11 |
| Profit before tax | 0.34 | 0.67 | 0.85 | -0.07 | 1.52 | 0.97 | 0.97 | -0.07 | 1.78 | 1.12 | 0.21 | -0.15 |
| Tax % | 0 | 0 | 35.29 | 14.29 | 1.97 | -3.09 | 449.48 | -42.86 | 21.35 | 33.04 | 47.62 | 20 |
| Net Profit | 0.33 | 0.67 | 0.54 | -0.08 | 1.48 | 1.01 | -3.39 | -0.04 | 1.4 | 0.76 | 0.1 | -0.18 |
| EPS in Rs | 0.44 | 0.9 | 0.73 | -0.11 | 1.99 | 1.36 | -4.57 | -0.05 | 1.89 | 0.98 | 0.13 | -0.23 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 29.01 | 31.03 | 37.54 | 25.18 | 40.13 | 46.78 | 47.92 | 50.2 | 47.47 | 45.62 |
| Expenses | 28.68 | 30.54 | 36.86 | 27.77 | 39.02 | 48.94 | 46.65 | 46.31 | 43.71 | 42.34 |
| Operating Profit | 0.33 | 0.49 | 0.68 | -2.59 | 1.11 | -2.16 | 1.27 | 3.89 | 3.76 | 3.28 |
| OPM % | 1.14 | 1.58 | 1.81 | -10.29 | 2.77 | -4.62 | 2.65 | 7.75 | 7.92 | 7.19 |
| Other Income | 0.41 | 0.32 | 0.29 | 0.62 | 0.31 | 0.35 | 0.32 | 0.31 | -0.12 | 0.29 |
| Interest | 0.23 | 0.25 | 0.29 | 0.39 | 0.4 | 0.72 | 0.68 | 0.42 | 0.18 | 0.17 |
| Depreciation | 0.19 | 0.21 | 0.24 | 0.18 | 0.28 | 0.36 | 0.37 | 0.38 | 0.42 | 0.44 |
| Profit before tax | 0.32 | 0.35 | 0.44 | -2.54 | 0.74 | -2.89 | 0.54 | 3.4 | 3.04 | 2.96 |
| Tax % | 15.62 | -25.71 | 36.36 | -0.39 | -17.57 | -42.21 | 55.56 | 128.53 | 27.3 | — |
| Net Profit | 0.27 | 0.43 | 0.28 | -2.52 | 0.87 | -1.67 | 0.24 | -0.98 | 2.2 | 2.08 |
| EPS in Rs | 0.36 | 0.58 | 0.38 | -3.4 | 1.17 | -2.25 | 0.32 | -1.32 | 2.82 | 2.77 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.79 |
| Reserves | 2.64 | 2.98 | 3.41 | 3.69 | 0.24 | 1.11 | -0.56 | -0.31 | -0.94 | 1.94 |
| Borrowings | 7 | 0.37 | 0.68 | 2.6 | 4.74 | 6.67 | 7.27 | 3.87 | 0.94 | 1.3 |
| Other Liabilities | 6.59 | 8.69 | 7.94 | 8.8 | 9.47 | 12.19 | 14.39 | 12.29 | 15.41 | 13.52 |
| Total Liabilities | 23.65 | 19.46 | 19.45 | 22.51 | 21.87 | 27.39 | 28.52 | 23.27 | 22.83 | 24.55 |
| Fixed Assets | 6.17 | 1.88 | 2.06 | 2.29 | 2.45 | 4.29 | 3.99 | 3.69 | 3.65 | 3.25 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.24 | 0.27 | 0.29 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.52 | 1.35 |
| Other Assets | 17.24 | 17.31 | 17.1 | 19.95 | 19.15 | 22.83 | 24.26 | 19.31 | 18.66 | 19.95 |
| Total Assets | 23.65 | 19.46 | 19.45 | 22.51 | 21.87 | 27.39 | 28.52 | 23.27 | 22.83 | 24.55 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.24 | 4.58 | -0.61 | -1.59 | -0.16 | -0.44 | 0.03 | 2.6 | 3.06 | 1.71 |
| Cash from Investing Activity | 0.18 | 1.11 | -0.13 | -0.27 | -0.42 | -0.87 | 0.62 | -0.46 | 0.46 | -0.11 |
| Cash from Financing Activity | -0.36 | -5.39 | 0.2 | 1.72 | 1.83 | 1.53 | -0.12 | -4.08 | -2.83 | 0.47 |
| Net Cash Flow | 0.06 | 0.29 | -0.55 | -0.14 | 1.24 | 0.22 | 0.52 | -1.94 | 0.69 | 2.08 |
| Free Cash Flow | 0.23 | 4.45 | -1.01 | -2.07 | -0.66 | -2.55 | -0.03 | 2.53 | 3.41 | 1.69 |
| CFO/OP | 688 | 1418 | -98 | -219 | 0 | -31 | -3 | 205 | 81 | 45 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 114.31 | 57.62 | 53.29 | 68.16 | 74.94 | 49.75 | 62.34 | 43.11 | 36.86 | 37.45 |
| Inventory Days | 150.01 | 126.33 | 114.69 | 90 | 136.65 | 153.9 | 83.56 | 81.09 | 70.81 | 79.43 |
| Days Payable | 59.7 | 110.67 | 85.26 | 83.44 | 104.13 | 96.22 | 110.35 | 97.39 | 69.65 | 33.65 |
| Cash Conversion Cycle | 204.61 | 73.29 | 82.72 | 74.72 | 107.46 | 107.43 | 35.56 | 26.81 | 38.02 | 83.23 |
| Working Capital Days | 86.74 | 20.89 | 27.88 | 25.18 | -14.06 | 6.82 | -20.21 | -7.69 | -13.89 | -5.77 |
| ROCE % | 1.91 | 2.95 | 5.39 | 5.79 | -15.09 | 8.26 | -14.8 | 9.72 | 41.41 | 39.24 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 36.78% | 37.01% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 37.03% | 40.03% | 40.03% | 40.03% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 57.49% | 58.47% | 59.92% | 59.87% | 59.62% | 59.44% | 59.34% | 59.12% | 58.49% | 54.43% | 54.58% | 54.37% |
| Others | 5.74% | 4.53% | 3.05% | 3.1% | 3.35% | 3.53% | 3.63% | 3.85% | 4.48% | 5.54% | 5.39% | 5.61% |
| No. of Shareholders | 13404 | 13327 | 13203 | 13394 | 13538 | 13710 | 13764 | 13804 | 13812 | 13812 | 13750 | 13755 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 40.02 | Buy |
| EMA (10) | 40.09 | Buy |
| SMA (20) | 38.75 | Buy |
| EMA (20) | 39.29 | Buy |
| SMA (50) | 37.29 | Buy |
| EMA (50) | 37.93 | Buy |
| SMA (100) | 36.36 | Buy |
| EMA (100) | 37.59 | Buy |
| SMA (200) | 39.08 | Buy |
| EMA (200) | 40.05 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 59.84 | Neutral |
| MACD (12,26,9) | 0.97 | Buy |
| Stochastic (14,3,3) | 79.28 | Neutral |
| ADX (14) | 15.33 | Neutral |
| Williams %R (14) | -8.63 | Sell |
| ATR (14) | 3.34 | High Volatility |
| ROC (12) | 10.31 | Buy |
| Stoch RSI (14) | 99.18 | Sell |
| UO (7,14,28) | 66.19 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a29ba12b-727b-46ae-a1bf-bc63ad3205fc.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7baccaf1-b40c-4f08-bdc7-4abd6d34b390.pdf) |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b6ab9ca-3422-4478-9df9-3ef8ab3448ae.pdf) |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a931ddef-4213-46ee-9530-e3de750df69b.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9465325f-f712-4a1c-a404-58824fcde74e.pdf) |
| 2026-08-07 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 7 August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fce555d5-f572-4bab-a394-b42aa3a4031f.pdf) |
| 2026-08-01 | [Board Meeting Intimation for Approving The Unaudited Standalone Financial Results Of The Company For The First Quarter Ended On 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f317176-6786-4c1d-826a-6bb67575c947.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28d08543-a050-4392-93ce-8731345681ec.pdf) |
| 2026-07-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=038768d5-3699-46fe-9f7d-8010be793ea7.pdf) |
| 2026-07-28 | [41St AGM Of The Shareholders Of Gujarat Terce Laboratories Limited Will Be Held On 21St August 2026 At 12:00 Noon.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4c4cb21-3e99-416b-b3da-5a15936f3e67.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30 June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd04405f-1395-4fbe-a1d7-dacdd6817631.pdf) |
| 2026-05-29 | [Financial Results For The Fourth Quarter And Year Ended 31 March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59e2ed33-34b1-4b4b-888e-2b542520b4d6.pdf) |
| 2026-02-04 | [Unaudited Standalone Financial Results Of The Company For The Third Quarter And Nine Months Ended 31 December 2025 Subjected To Limited Review Of The Statutory Auditor Of The Company - Regulations 30 And 33 Of The Securities And Exchange Board Of India (L](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89a46606-b3e1-48d8-8134-2b303100abae.pdf) |
| 2025-11-08 | [Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025 - Regulations 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b712a432-ca08-488a-ae94-aaf68897d0cc.pdf) |
| 2025-08-11 | [Un-Audited Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57f6f1cb-07da-4b41-b6b0-02b36ec668a3.pdf) |
| 2025-05-26 | [Results-Financial Results For The Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=147ac623-6f8b-48eb-94bd-3803e15b5600.pdf) |
| 2025-02-04 | [Results - Unaudited For Quarter Ended 31.12.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e1fc45-e24a-48dd-a7e4-60c311aa9801.pdf) |
| 2024-10-28 | [Unaudited Standalone Financial Results For The Quarter And Half Year Ended On September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9ae3c78-459d-46c4-9d37-0c9af2703f4f.pdf) |
| 2024-08-09 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afa85f32-c09f-4aa1-8462-7601aa003070.pdf) |
| 2024-05-29 | [Results- Financial Results For Year Ended 31St March, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d6a8703-1b59-40ff-9c95-7b789c171f71.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-06-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0962358f-d39a-4415-a050-5854dd28e723.pdf) |
| 2026-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2861360-df15-484f-9548-6d5738f453af.pdf) |
| 2025-11-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18e006e5-30f7-4e89-8a42-e14bb61e7905.pdf) |
| 2025-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5182c72-0093-4b73-b9fc-61c2e98c5346.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2997166-45e2-4310-93de-ec42a52e8772.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d9da9bd-cb00-495f-aafc-0edcbd7f882b.pdf) |
| 2025-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45e5df06-c9c0-44ee-b2ea-71a49cfa70ed.pdf) |
| 2024-10-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b29e2c5a-07bd-45d0-a181-b04c887392f6.pdf) |
| 2024-08-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2c3fce9-86c6-4b15-ae2a-3f6990972a4d.pdf) |
| 2024-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb6c9eeb-67ac-4167-9b1d-ac9d1ccdf526.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b29e2c5a-07bd-45d0-a181-b04c887392f6.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a67bf9b-c3c4-4090-b77c-02e57e6882ce.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18e006e5-30f7-4e89-8a42-e14bb61e7905.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f255d4bb-cfa1-4aff-94f2-c6124ac5a82f.pdf) |
| Nov 2017 | [Concall - Nov 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/11/8faa989e-8e9d-4ac4-90e2-fa379f2771d4.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e2997166-45e2-4310-93de-ec42a52e8772.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eb6c9eeb-67ac-4167-9b1d-ac9d1ccdf526.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0cc43627-8a91-438b-8868-71a0e7e560e2.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f56cae63-526d-497e-8f5a-a1a19359ee73.pdf) |
| Mar 2018 | [Concall - Mar 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/3/d7951aee-a156-474f-8dfa-0600afcc0102.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7h - Mercury Travels Pvt Ltd incorporated March 9, 2026; 100% subscribed by Ebix Travels; ₹5 lakh initial subscription. | [Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - Incorporation Of Step-Down Subsidiary Of The Company 7h - Mercury Travels Pvt Ltd incorporated March 9, 2026; 100% subscribed by Ebix Travels; ₹5 lakh initial subscription.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3dd529d9-69a3-458d-8fe1-433078ab9fd6.pdf) |
| 6 Apr - Certificate received from Bigshares Services Private Limited, the Registrar and Share Transfer Agent, in respect of the dematerialisation request received by them for the Company … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Certificate received from Bigshares Services Private Limited, the Registrar and Share Transfer Agent, in respect of the dematerialisation request received by them for the Company …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cc1be69-4dce-404e-8435-ea28ca25ae16.pdf) |
| 4 Feb - Unaudited standalone results for Q3 and nine months ended 31 Dec 2025 approved; limited review unmodified. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 4 February 2026 4 Feb - Unaudited standalone results for Q3 and nine months ended 31 Dec 2025 approved; limited review unmodified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eb7c6469-e966-4acd-bc6d-e982cd227a3a.pdf) |
| 4 Feb - Statutory auditor M.A. Shah & Co. renamed Shah Doshi Patel & Associates LLP, effective 4 Feb 2026. | [Change Of Name Of Company'S Statutory Auditor 4 Feb - Statutory auditor M.A. Shah & Co. renamed Shah Doshi Patel & Associates LLP, effective 4 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4975824c-54ea-45f9-b76d-285eddefd441.pdf) |
| 4 Feb - Investor Presentation for third quarter and nine months ended on 31 December 2025 | [Announcement under Regulation 30 (LODR)-Investor Presentation 4 Feb - Investor Presentation for third quarter and nine months ended on 31 December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2861360-df15-484f-9548-6d5738f453af.pdf) |
| 2d - Rights issue INR 99.76 crore raised 10-11-2025; no deviation, allocations fully utilized by Dec 31, 2025. | [Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended December 31, 2025. 2d - Rights issue INR 99.76 crore raised 10-11-2025; no deviation, allocations fully utilized by Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2e17bb70-ac64-4c0f-a45f-c620792bcd41.pdf) |
| 2d - Feb 14: Deferred Q3/9M Dec 31, 2025 results; three executive directors appointed; Rs99.76 crore rights issue fully utilized. | [Announcement under Regulation 30 (LODR)-Change in Management 2d - Feb 14: Deferred Q3/9M Dec 31, 2025 results; three executive directors appointed; Rs99.76 crore rights issue fully utilized.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c69d3b4f-167b-4d48-a57d-4ec2f1fe41eb.pdf) |
| 2d - Board appointed three executive directors (Feb 14, 2026); Q3 results deferred; Rights Issue Rs.99.76 crore fully utilized. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, February 14, 2026 2d - Board appointed three executive directors (Feb 14, 2026); Q3 results deferred; Rights Issue Rs.99.76 crore fully utilized.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3878b3b0-f3d0-41d2-98a3-390850a62f30.pdf) |
| 24 Feb - Trading approval for 3,71,000 shares (Rs.27.70 premium) to Mr. Aalap Prajapati; listed effective Feb 25, 2026. | [Intimation Of Trading Approval For 3,71,000 Equity Shares Of Face Value Rs. 10/- Each Allotted Pursuant To Conversion Of Warrants Issued On Preferential Basis From BSE Limited 24 Feb - Trading approval for 3,71,000 shares (Rs.27.70 premium) to Mr. Aalap Prajapati; listed effective Feb 25, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ae42f53-d43b-4019-96ce-1f3d3b0bb48a.pdf) |
| 23h - Allotted 16,35,11,850 bonus shares (2:1); record date Feb 14, 2026; capital increases to Rs49,05,35,550. | [Announcement under Regulation 30 (LODR)-Allotment 23h - Allotted 16,35,11,850 bonus shares (2:1); record date Feb 14, 2026; capital increases to Rs49,05,35,550.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1e394fe3-2b99-4e37-b3f4-23c7b2c495f0.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/038768d5-3699-46fe-9f7d-8010be793ea7.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92af7489-902e-49e4-a53c-0befd8b4149c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de23fbfd-3bfe-4f22-9998-e668fcafc747.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d732f0c-70ae-4616-92a0-6e9c4f286a63.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61fa80ce-5f07-4518-bd70-114759649bb7.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e3f58d9-4c55-4bbf-a15e-5badcf7e891c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b32d9af-b7c0-4450-b2c7-1110b97d8c6a.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533452/74182533452.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524314/74015524314.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533452/70709533452_04_09_21.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:35.701Z.